These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 34737698)

  • 1. Network Pharmacology-Based Identification of Key Mechanisms of Xihuang Pill in the Treatment of Triple-Negative Breast Cancer Stem Cells.
    Zhang YZ; Yang JY; Wu RX; Fang C; Lu H; Li HC; Li DM; Zuo HL; Ren LP; Liu XY; Xu R; Wen JH; Huang HD; Hong R; Chen QJ
    Front Pharmacol; 2021; 12():714628. PubMed ID: 34737698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Target and Mechanism of the Xihuang Pill Based on Network Pharmacology for Lung Squamous Cell Carcinoma.
    Tu H; Li J; Xu W; Wang Z; Wang L
    Altern Ther Health Med; 2023 Oct; 29(7):148-154. PubMed ID: 37442189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A study on molecular mechanism of Xihuang pill in the treatment of glioblastoma based on network pharmacology and validation in vitro and in vivo.
    Xu HB; Chen XZ; Zhu SY; Xue F; Zhang YB
    J Ethnopharmacol; 2024 Apr; 323():117675. PubMed ID: 38159819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systems pharmacology in combination with proteomics reveals underlying mechanisms of Xihuang pill against triple-negative breast cancer.
    Xu X; Zhang J; Zhang Z; Wang M; Liu Y; Li X
    Bioengineered; 2020 Dec; 11(1):1170-1188. PubMed ID: 33092442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Based on BATMAN-TCM to Explore the Molecular Mechanism of Xihuang Pill Regulating Immune Function to Treat Breast Precancerous Lesions.
    Li D; Fan H; Dong J; Sun C; Su Y; Liu J; Gu Y
    Breast Cancer (Dove Med Press); 2021; 13():725-742. PubMed ID: 34992452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring the Regulation Mechanism of Xihuang Pill,
    Yang K; Zeng L; Ge A; Bao T; Xu T; Xie X; Liu L
    Front Pharmacol; 2020; 11():825. PubMed ID: 32595497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Xihuang pill in the treatment of cancer: TCM theories, pharmacological activities, chemical compounds and clinical applications.
    Xu HB; Chen XZ; Wang X; Pan J; Yi-Zhuo Z; Zhou CH
    J Ethnopharmacol; 2023 Nov; 316():116699. PubMed ID: 37257709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of serum containing Xihuang pill on proliferation of human breast cancer cell line MDA-MB-435 and MCF-7 Cells].
    He LJ; Li JS; Chen X; Zhang HT; Zhu XG; Zhang XD; Xie SH; Gu HO
    Zhongguo Zhong Yao Za Zhi; 2018 Jul; 43(13):2784-2788. PubMed ID: 30111032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Network Pharmacology-Based Strategy for Predicting Therapy Targets of Traditional Chinese Medicine Xihuang Pill on Liver Cancer.
    Zhao X; Hao J; Chen S
    Evid Based Complement Alternat Med; 2020; 2020():6076572. PubMed ID: 32256653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Virtual screening of the multi-gene regulatory molecular mechanism of Si-Wu-tang against non-triple-negative breast cancer based on network pharmacology combined with experimental validation.
    Zhang Z; Liu J; Liu Y; Shi D; He Y; Zhao P
    J Ethnopharmacol; 2021 Apr; 269():113696. PubMed ID: 33358854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Network Pharmacology-Oriented Identification of Key Proteins and Signaling Pathways Targeted by Xihuang Pill in the Treatment of Breast Cancer.
    Wu J; Luo D; Li S
    Breast Cancer (Dove Med Press); 2020; 12():267-277. PubMed ID: 33324095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systems biology strategy and experimental validation to uncover the pharmacological mechanism of Xihuang Pill in treating non-small cell lung cancer.
    Zhuang Z; Huang D; Sheng ZR; Ye ZJ; Jiang H; Yuan Y; Qin B; Zhao Y; Pan HF; Tang Y
    Phytomedicine; 2023 Jan; 108():154491. PubMed ID: 36368285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prospect of
    Chen Z; Li Z; Yang S; Wei Y; An J
    Heliyon; 2023 Apr; 9(4):e15490. PubMed ID: 37128341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Xihuang pill potentiates the anti-tumor effects of temozolomide in glioblastoma xenografts through the Akt/mTOR-dependent pathway.
    Fu J; Zhu SH; Xu HB; Xu YQ; Wang X; Wang J; Kong PS
    J Ethnopharmacol; 2020 Oct; 261():113071. PubMed ID: 32603676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Mechanism of anti-hyperplasia of mammary glands of Xihuang Pills blood-entering component based on UPLC-Q-TOF-MS and network pharmacology].
    Fan QR; Chen M; Dong XY; Tao R; Wang JR; Xia SL; Lan YM; Han T
    Zhongguo Zhong Yao Za Zhi; 2023 Dec; 48(24):6749-6764. PubMed ID: 38212035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulatory effects of Xihuang Pill on lung cancer treatment by an integrative approach.
    Li C; Chen W; Zhang M; Zhang C; Cao B; Dong B; Qi S; Zhang Y; Fei X; Li X; Li R; Wang J; Li G
    Biomed Pharmacother; 2020 Oct; 130():110533. PubMed ID: 32739739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Integrative Metabolomic and Network Pharmacology Study Revealing the Regulating Properties of Xihuang Pill That Improves Anlotinib Effects in Lung Cancer.
    Li C; Wang Z; Chen W; Cao B; Zhang M; Gu Q; Qi S; Fei X; Shi Y; Li X; Li R; Wang J; Li G
    Front Oncol; 2021; 11():697247. PubMed ID: 34434895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple effects of Xihuang pill aqueous extract on the Hs578T triple-negative breast cancer cell line.
    Zheng W; Han S; Jiang S; Pang L; Li X; Liu X; Cao M; Li P
    Biomed Rep; 2016 Nov; 5(5):559-566. PubMed ID: 27882217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uncovering the mechanisms of dandelion against triple-negative breast cancer using a combined network pharmacology, molecular pharmacology and metabolomics approach.
    Qu J; Ke F; Liu Z; Yang X; Li X; Xu H; Li Q; Bi K
    Phytomedicine; 2022 May; 99():153986. PubMed ID: 35183931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of triptonide as a therapeutic agent for triple negative breast cancer treatment.
    Gao B; Chen J; Han B; Zhang X; Hao J; Giuliano AE; Cui Y; Cui X
    Sci Rep; 2021 Jan; 11(1):2408. PubMed ID: 33510281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.